Ogkologos | Ogkologos.com | Page 78

Home Authors Posts by Ogkologos

4396 POSTS 0 COMMENTS

EMA Recommends Granting a Marketing Authorisation for Erdafitinib

Ogkologos - July 10, 2024

Trial Establishes Preferred Treatment for Some People with Esophageal Cancer

Ogkologos - July 9, 2024

Adjuvant Dabrafenib Plus Trametinib Associated with Better RFS and DMFS than...

Ogkologos - July 9, 2024

FDA Grants Accelerated Approval to Repotrectinib for Adult and Paediatric Patients...

Ogkologos - July 8, 2024

Amivantamab Plus Lazertinib Shows Superior Efficacy to Osimertinib in First-Line Treatment...

Ogkologos - July 5, 2024

Treatment with Brigatinib Results in Radiographic Responses and Clinical Benefit in...

Ogkologos - July 4, 2024

Program Helps Medically Underserved, Minority Cancer Survivors Be More Active

Ogkologos - July 3, 2024

Belantamab Mafodotin–Containing Triplets Confer a Significant PFS Benefit Among Previously Treated...

Ogkologos - July 3, 2024

FDA Grants Traditional Approval to Selpercatinib for RET Fusion-positive Thyroid Cancer

Ogkologos - July 2, 2024

Tumor Signatures May Help Explain Global Differences in Kidney Cancer Rates

Ogkologos - July 1, 2024

1...777879...440 Page 78 of 440

MOST POPULAR

Addressing Common Concerns Around Taking Opioids for Cancer-Related Pain: An Expert...

July 5, 2023

Tagraxofusp Proves Effective for BPDCN, A Rare Blood Cancer

May 15, 2019

5-Yr-Old Has Cutest Celebration With Big Brother After Being Declared Cancer-Free.

May 21, 2019

How MRI add-ons could accelerate the development of new treatments

May 9, 2023

HOT NEWS

Man Gives Up His First-Class Seat For 88-Year-Old Woman, Makes Her...

Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer

Telehealth Can Save People with Cancer Time, Travel, and Money

Taking on the RAS Challenge